Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ShangPharma Appoints CSO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

ShangPharma Appoints CSO

Taveras brings extensive experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Art Taveras has been appointed president and chief scientific officer at ShangPharma Corp. Dr. Taveras brings extensive pharmaceutical leadership and technical expertise in drug discovery, chemistry R&D and pharmaceutical development, having held executive roles at pharma and biopharma companies during his 24-year career.  
 
Prior to joining the company, Dr. Taveras served as vice president Small Molecules Drug Discovery, vice president Chemistry R&D, and vice president CMC Development at Biogen Idec, leading the discovery and CMC development of neurology, immunology and oncology drug candidates at its multiple sites and partnerships in the U.S. and abroad. Dr. Taveras also served as vice president of Drug Discovery and CMC Development at Alantos Pharmaceuticals, leading the discovery research and building its Diabetes and Matrix Metalloproteinase franchise in the U.S. and Germany. Dr. Taveras began his career with Schering-Plough, where he spent 14 years in Oncology and Immunology Drug Discovery Research.
 
“We are so pleased that Dr. Taveras has joined the company,” said Michael Hui, chairman and chief executive officer of ShangPharma Corp. “His extensive leadership, strategic and technical experience at the highest levels in pharmaceutical drug discovery and development will be a great asset to the company as it strives to become the preferred small molecules and biologics drug discovery partner for biopharmaceutical companies. Under Dr. Taveras’ leadership, there will be so much to be looking forward to.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics